UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form SD

 

Specialized Disclosure Report

 

BRUKER CORPORATION

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

000-30833

 

04-3110160

(State or Other Jurisdiction of

 

(Commission File Number)

 

(IRS Employer Identification

Incorporation)

 

 

 

Number)

 

40 Manning Road, Billerica, MA 01821

(Address of principal executive offices) (Zip Code)

 

 

Gerald N. Herman

(978) 663-3660

 

(Name and telephone number, including area code, of the person to contact in
connection with this report.)

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

xRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.

 

 

 



 

Section 1 — Conflict Minerals Disclosure

 

Item 1.01 Conflict Minerals Disclosure and Report

 

Pursuant to Rule 13p-1 (“Rule 13p-1”) promulgated under the Securities Exchange Act of 1934, as amended, Bruker Corporation (the “Company”) has filed this Specialized Disclosure Report (“Form SD”) for the reporting period January 1, 2017 to December 31, 2017.

 

A description of the measures the Company undertook to exercise due diligence on the source and chain of custody of conflict minerals contained in its Products is provided in the Conflict Minerals Report attached hereto as Exhibit 1.01. A copy of the Company’s Conflict Minerals Report is publicly available at www.bruker.com.

 

Item 1.02 Exhibits

 

As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this Form SD.

 

Section 2 — Exhibits

 

Item 2.01 Exhibits

 

The following exhibit is filed as part of this report:

 

Exhibit 1.01 — Conflict Minerals Report of Bruker Corporation

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

Bruker Corporation

 

 

 

By:

/s/ GERALD N. HERMAN

Date: May 31, 2018

 

Gerald N. Herman

 

 

Interim Chief Financial Officer and Vice President

 

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

3